動物バイオテクノロジー市場の規模、シェア、動向分析レポート：製品タイプ別（診断テスト、ワクチン、薬剤）、用途別、動物タイプ別、最終用途別、地域別、セグメント別予測、2022年～2030年

動物バイオテクノロジー市場の成長と動向

Grand View Research, Inc.の新しいレポートによると、世界の動物バイオテクノロジー市場規模は2030年までに490億7000万米ドルに達すると予想されています。

2022年から2030年までCAGR9.2%で拡大すると予測されています。主な成長要因は、政府の取り組みやキャンペーン、アニマルヘルスバイオテクノロジーの革新や最近の進歩、動物遺伝子検査に関する教育への取り組みの高まり、人獣共通感染症の発生率の上昇などです。例えば、2021年1月、カナダとオンタリオ州の政府は、カナダ農業パートナーシップを通じて最大400万米ドルを提供し、農家が必要とするときと場所で獣医サービスへのアクセス向上を提供します。

世界中でCOVID-19の流行が増加しているため、多くの国が、動物医療には緊急または急を要する処置のみが確実に必要であると規定しました。ワクチン接種などの日常診療の遅れは、ある種の深刻な健康問題や福祉問題につながっています。さらに、COVID-19規制解除後の過剰な業務が、こうしたサービスの提供にさらなる遅れを生じさせています。獣医師の訪問と診断検査は、2020年3月、4月、5月に大幅に減少したが、2020年第3四半期から高い成長率で改善し始めました。

主要プレイヤーは、制限とサプライチェーンの混乱にもかかわらず、パンデミックの間に成長を観察しました。Neogen Corporationの2020年度の連結売上高は4億1820万米ドルで、2019年度と比較して1.0％の上昇となっています。さらに、2022年6月にはインド初の動物用COVID-19ワクチン「アノコバックス」を発売。Anocovacのほか、インドの農業大臣は、イヌのSARS-CoV-2に対する抗体検出のための「CAN-CoV-2 ELISAキット」--特定のヌクレオカプシド蛋白を用いた間接ELISAキット--を発表しました。このような市場開拓は、市場全体の成長を促進します。

その他、農業における動物利用の需要向上、動物の健康と福祉、食肉、動物由来製品への意識の高まり、ヒト用医薬品の開発における動物の役割の拡大、ペットの飼育数の増加、市場関係者による研究開発投資の増加などが、業界成長の要因となっています。2021年8月、INDICAL BIOSCIENCE GmbHがオランダの研究開発特化型企業であるCheck-Pointsを買収しました。

業界は、主要プレイヤーが市場浸透度を向上させるために、製品イノベーション、新製品開発、流通契約、拡大戦略に注力しているため、競争が激しいです。2021年10月、Embark Veterinary, Inc.は純血種の犬用DNA検査をリリースしました。このキットは、純血種の飼い主に、ピンポイントの診断、治療計画、モニタリングを支援する独占的な実用的な健康情報を提供し、獣医師と簡単に共有することができるものです。

動物バイオテクノロジー市場レポートハイライト

ワクチン製品タイプは、2021年に最大の収益を上げるセグメントとなりました。ワクチン接種は動物の疾病負担を下げる効果的な方法であり、予防ヘルスケアや疾病管理において重要な役割を担っています。2021年12月、Indian Immunologicals Ltd.はヤギ痘ワクチンを発表した

コンパニオンアニマルの導入が進んでいることから、2021年には動物の予防医療用途のセグメントが最大の収益シェアを占めました。HABRIとZoetisによる国際的な調査では、人間と動物の絆と一貫した獣医療との間に直接的な関係があることが示されています。したがって、このような人間と動物の絆は、より良い予防医療に進みます

コンパニオンアニマルタイプのセグメントは、効率的な動物医療への需要の増加と、それに伴う健康上のメリットによるペットと人間の絆によって、予測期間中に大きく成長する可能性があります。

コンパニオンアニマルタイプのセグメントでは、2021年に犬が最大の収益シェアを占めました。犬は、人間が罹患するのと同じ癌の多くに罹患する傾向があります。米国国立がん研究所によると、毎年600万件近くのがんが新たに犬で診断されています。

その他、最終用途セグメントでは、高度な診断ツールや治療的に高度なワクチンや医薬品を開発するための研究開発資金の増加により、獣医学研究機関や大学が予測期間中に有利な速度で成長すると予想される

北米は、動物に対する高い認識レベル、確立された市場プレイヤーの存在、ヘルスケアインフラの改善により、2021年に最大の収益シェアを占めました。2021年10月、Zoetis Inc.がアイルランドのタラモアに製造・開発施設を拡張

目次

第1章 調査手法と範囲

• 市場セグメンテーションと範囲
  • セグメントの範囲
  • 地域範囲
  • 推定・予測のタイムライン
• 調査手法
• 情報調達
  • 購入したデータベース
  • GVRの内部データベース
  • 二次情報
  • 1次調査
  • 1次調査内容
• 情報またはデータ分析
  • データ分析モデル
• 市場の策定と検証
• モデルの詳細
• 二次情報一覧
• 目的

第2章 エグゼクティブサマリー

• 2021年の市場スナップショット（100万米ドル）

第3章 市場変数、動向、範囲

• 市場系列の見通し
  • 親市場の見通し
  • アンシラリー市場の見通し
• 浸透と成長の見通しのマッピング
• 規制の枠組み
• 主要な地域別動物の個体数の推定
• バリューチェーン分析
• 消費者の嗜好分析
• 製品パイプライン分析
• 市場のダイナミクス
  • 市場促進要因分析
  • 市場制約分析
  • 市場機会分析
  • 市場課題分析
• 業界分析
  • ポーターズ
  • 乳棒
• COVID-19影響分析
  • 現在および将来の影響分析
  • COVID-19が市場関係者に与える影響

第4章 競合情勢

• Market participation categorization
• Company Dashboard Analysis
• Public Companies
  • 会社の市況分析
  • 相乗効果分析：主要取引と戦略的提携
• List of Market Players

第5章 動物バイオテクノロジー市場：製品タイプの推定・動向分析

• 動物バイオテクノロジー市場：製品タイプの変動分析
• 診断テスト
• ワクチン
  • ワクチン市場、2017～2030年（100万米ドル）
• 薬物
  • 医薬品市場、2017年から2030年（100万米ドル）
• 生殖と遺伝
  • 生殖および遺伝子市場、2017～2030年（100万米ドル）
• 飼料添加物

第6章 動物バイオテクノロジー市場：アプリケーションの推定・動向分析

• 動物バイオテクノロジー市場：アプリケーションの変動分析
• 動物の病気の診断
• 動物の病気の治療
  • 2017年から2030年までの動物疾患の治療市場（100万米ドル）
• 動物の予防ケア
  • 動物の予防ケア市場、2017年～2030年（100万米ドル）
• 医薬品開発
  • 医薬品開発市場、2017～2030年（USD Million）
• その他

第7章 動物バイオテクノロジー市場：動物タイプ別の推定・動向分析

• アニマルバイオテクノロジー市場：動物タイプの変動分析
• コンパニオンアニマル
  • 犬
  • 猫
  • 馬
  • その他
• 生産動物
  • 家禽
  • 豚
  • 牛
  • 羊とヤギ
  • その他

第8章 動物バイオテクノロジー市場：最終用途の推定・動向分析

• 動物バイオテクノロジー市場：最終用途の変動分析
• 研究所
• ポイントオブケア検査・院内検査
  • ポイントオブケア検査/院内検査市場、2017年～2030年（100万米ドル）
• 動物病院および診療所
  • 動物病院およびクリニック市場、2017年～2030年（100万米ドル）
• その他
  • その他の市場、2017年から2030年（USD Million）

第9章 動物バイオテクノロジー市場：製品タイプ別、アプリケーション別、動物タイプ別、および最終用途別の地域推定・動向分析

• 2017年から2030年までの地域別の動物バイオテクノロジー市場シェア（100万米ドル）
• 北米
  • 米国
  • カナダ
• 欧州
  • 欧州の動物バイオテクノロジー市場、2017年～2030年（100万米ドル）
  • ドイツ
    • ドイツの動物バイオテクノロジー市場（USD Million）
  • 英国
    • 英国の動物バイオテクノロジー市場、2017年から2030年（100万米ドル）
  • フランス
    • フランスの動物バイオテクノロジー市場、2017年～2030年（100万米ドル）
  • イタリア
    • イタリアの動物バイオテクノロジー市場、2017年～2030年（100万米ドル）
  • スペイン
    • スペインの動物バイオテクノロジー市場、2017年から2030年（100万米ドル）
• アジア太平洋地域
  • アジア太平洋動物バイオテクノロジー市場、2017年から2030年（100万米ドル）
  • 日本
    • 日本のアニマルバイオテクノロジー市場、2017年～2030年（USD Million）
  • 中国
    • 中国の動物バイオテクノロジー市場、2017年～2030年（100万米ドル）
  • インド
    • インドの動物バイオテクノロジー市場、2017年～2030年（100万米ドル）
  • オーストラリア
    • オーストラリアの動物バイオテクノロジー市場、2017年～2030年（100万米ドル）
• ラテンアメリカ
  • ラテンアメリカの動物バイオテクノロジー市場、2017年～2030年（100万米ドル）
  • ブラジル
    • ブラジルの動物バイオテクノロジー市場2017～2030年（USD Million）
  • メキシコ
    • メキシコの動物バイオテクノロジー市場2017～2030年（100万米ドル）
  • アルゼンチン
    • アルゼンチンの動物バイオテクノロジー市場2017～2030年（100万米ドル）
• MEA
  • MEA動物バイオテクノロジー市場、2017年～2030年（百万米ドル）
  • サウジアラビア
    • サウジアラビアの動物バイオテクノロジー市場、2017～2030年（100万米ドル）
  • 南アフリカ
    • 南アフリカの動物バイオテクノロジー市場、2017年～2030年（100万米ドル）

第10章 企業プロファイル

• Zoetis
  • 会社概要
  • 財務実績
  • 製品のベンチマーク
  • 戦略的イニシアチブ
• Boehringer Ingelheim International GmbH
  • 会社概要
  • 財務実績
  • 製品のベンチマーク
  • 戦略的イニシアチブ
• Biogenesis Bago
  • 会社概要
  • 財務実績
  • 製品のベンチマーク
  • 戦略的イニシアチブ
• Merck &Co.,Inc.
  • 会社概要
  • 財務実績
  • 製品のベンチマーク
  • 戦略的イニシアチブ
• Virbac
  • 会社概要
  • 財務実績
  • 製品のベンチマーク
  • 戦略的イニシアチブ
• Elanco
  • 会社概要
  • 財務実績
  • 製品のベンチマーク
  • 戦略的イニシアチブ
• Idexx Laboratories
  • 会社概要
  • 財務実績
  • 製品のベンチマーク
  • 戦略的イニシアチブ
• Heska Corporation
  • 会社概要
  • 財務実績
  • 製品のベンチマーク
  • 戦略的イニシアチブ
• Indian Immunologicals Ltd.
  • 会社概要
  • 財務実績
  • 製品のベンチマーク
  • 戦略的イニシアチブ
• HESTER BIOSCIENCES LIMITED
  • 会社概要
  • 財務実績
  • 製品のベンチマーク
  • 戦略的イニシアチブ

List of Tables

• Table 1 Country Share Estimation
• Table 2 North America Animal Biotechnology Market, By Product Type, 2017 - 2030 (USD Million)
• Table 3 North America Animal Biotechnology Diagnostic Tests Market, By Type, 2017 - 2030 (USD Million)
• Table 4 North America Animal Biotechnology Vaccine Market, By Type, 2017 - 2030 (USD Million)
• Table 5 North America Animal Biotechnology Drugs Market, By Type, 2017 - 2030 (USD Million)
• Table 6 North America Animal Biotechnology Reproductive and Genetic Market, By Type, 2017 - 2030 (USD Million)
• Table 7 North America Animal Biotechnology Feed Additives Market, By Type, 2017 - 2030 (USD Million)
• Table 8 North America Animal Biotechnology Market, By Application, 2017 - 2030 (USD Million)
• Table 9 North America Animal Biotechnology Market, By Animal Type, 2017 - 2030 (USD Million)
• Table 10 North America Animal Biotechnology Market, By End-Use, 2017 - 2030 (USD Million)
• Table 11 U.S. Animal Biotechnology Market, By Product Type, 2017 - 2030 (USD Million)
• Table 12 U.S. Diagnostic Test Market, By Type, 2017 - 2030 (USD Million)
• Table 13 U.S. Vaccine Market, By Type, 2017 - 2030 (USD Million)
• Table 14 U.S. Drugs Market, By Type, 2017 - 2030 (USD Million)
• Table 15 U.S. Reproductive And Genetic Market, By Type, 2017 - 2030 (USD Million)
• Table 16 U.S. Feed Additives Market, By Type, 2017 - 2030 (USD Million)
• Table 17 U.S. Animal Biotechnology Market, By Application, 2017 - 2030 (USD Million)
• Table 18 U.S. Animal Biotechnology Market, By Animal Type, 2017 - 2030 (USD Million)
• Table 19 U.S. Animal Biotechnology Market, By End-Use, 2017 - 2030 (USD Million)
• Table 20 U.S. Animal Biotechnology Market, By Product Type, 2017 - 2030 (USD Million)
• Table 21 Canada Diagnostic Test Market, By Type, 2017 - 2030 (USD Million)
• Table 22 Canada Vaccine Market, By Type, 2017 - 2030 (USD Million)
• Table 23 Canada Drugs Market, By Type, 2017 - 2030 (USD Million)
• Table 24 Canada Reproductive And Genetic Market, By Type, 2017 - 2030 (USD Million)
• Table 25 Canada Feed Additives Market, By Type, 2017 - 2030 (USD Million)
• Table 26 Canada Animal Biotechnology Market, By Application, 2017 - 2030 (USD Million)
• Table 27 Canada Animal Biotechnology Market, By Animal Type, 2017 - 2030 (USD Million)
• Table 28 Canada Animal Biotechnology Market, By End-Use, 2017 - 2030 (USD Million)
• Table 29 Europe Animal Biotechnology Market, By Product Type, 2017 - 2030 (USD Million)
• Table 30 Europe Diagnostic Test Market, By Type, 2017 - 2030 (USD Million)
• Table 31 Europe Vaccine Market, By Type, 2017 - 2030 (USD Million)
• Table 32 Europe Drugs Market, By Type, 2017 - 2030 (USD Million)
• Table 33 Europe Reproductive And Genetic Market, By Type, 2017 - 2030 (USD Million)
• Table 34 Europe Feed Additives Market, By Type, 2017 - 2030 (USD Million)
• Table 35 Europe Animal Biotechnology Market, By Application, 2017 - 2030 (USD Million)
• Table 36 Europe Animal Biotechnology Market, By Animal Type, 2017 - 2030 (USD Million)
• Table 37 Europe Animal Biotechnology Market, By End-Use, 2017 - 2030 (USD Million)
• Table 38 Germany Animal Biotechnology Market, By Product Type, 2017 - 2030 (USD Million)
• Table 39 Germany Diagnostic Test Market, By Type, 2017 - 2030 (USD Million)
• Table 40 Germany Vaccine Market, By Type, 2017 - 2030 (USD Million)
• Table 41 Germany Drugs Market, By Type, 2017 - 2030 (USD Million)
• Table 42 Germany Reproductive And Genetic Market, By Type, 2017 - 2030 (USD Million)
• Table 43 Germany Feed Additives Market, By Type, 2017 - 2030 (USD Million)
• Table 44 Germany Animal Biotechnology Market, By Application, 2017 - 2030 (USD Million)
• Table 45 Germany Animal Biotechnology Market, By Animal Type, 2017 - 2030 (USD Million)
• Table 46 Germany Animal Biotechnology Market, By End-Use, 2017 - 2030 (USD Million)
• Table 47 U.K. Animal Biotechnology Market, By Product Type, 2017 - 2030 (USD Million)
• Table 48 U.K. Diagnostic Test Market, By Type, 2017 - 2030 (USD Million)
• Table 49 U.K. Vaccine Market, By Type, 2017 - 2030 (USD Million)
• Table 50 U.K. Drugs Market, By Type, 2017 - 2030 (USD Million)
• Table 51 U.K. Reproductive And Genetic Market, By Type, 2017 - 2030 (USD Million)
• Table 52 U.K. Feed Additives Market, By Type, 2017 - 2030 (USD Million)
• Table 53 U.K. Animal Biotechnology Market, By Application, 2017 - 2030 (USD Million)
• Table 54 U.K. Animal Biotechnology Market, By Animal Type, 2017 - 2030 (USD Million)
• Table 55 U.K. Animal Biotechnology Market, By End-Use, 2017 - 2030 (USD Million)
• Table 56 France Animal Biotechnology Market, By Product Type, 2017 - 2030 (USD Million)
• Table 57 France Diagnostic Test Market, By Type, 2017 - 2030 (USD Million)
• Table 58 France Vaccine Market, By Type, 2017 - 2030 (USD Million)
• Table 59 France Drugs Market, By Type, 2017 - 2030 (USD Million)
• Table 60 France Reproductive And Genetic Market, By Type, 2017 - 2030 (USD Million)
• Table 61 France Feed Additives Market, By Type, 2017 - 2030 (USD Million)
• Table 62 France Animal Biotechnology Market, By Application, 2017 - 2030 (USD Million)
• Table 63 France Animal Biotechnology Market, By Animal Type, 2017 - 2030 (USD Million)
• Table 64 France Animal Biotechnology Market, By End-Use, 2017 - 2030 (USD Million)
• Table 65 Italy Animal Biotechnology Market, By Product Type, 2017 - 2030 (USD Million)
• Table 66 Italy Diagnostic Test Market, By Type, 2017 - 2030 (USD Million)
• Table 67 Italy Vaccine Market, By Type, 2017 - 2030 (USD Million)
• Table 68 Italy Drugs Market, By Type, 2017 - 2030 (USD Million)
• Table 69 Italy Reproductive And Genetic Market, By Type, 2017 - 2030 (USD Million)
• Table 70 Italy Feed Additives Market, By Type, 2017 - 2030 (USD Million)
• Table 71 Italy Animal Biotechnology Market, By Application, 2017 - 2030 (USD Million)
• Table 72 Italy Animal Biotechnology Market, By Animal Type, 2017 - 2030 (USD Million)
• Table 73 Italy Animal Biotechnology Market, By End-Use, 2017 - 2030 (USD Million)
• Table 74 Spain Animal Biotechnology Market, By Product Type, 2017 - 2030 (USD Million)
• Table 75 Spain Diagnostic Test Market, By Type, 2017 - 2030 (USD Million)
• Table 76 Spain Vaccine Market, By Type, 2017 - 2030 (USD Million)
• Table 77 Spain Drugs Market, By Type, 2017 - 2030 (USD Million)
• Table 78 Spain Reproductive And Genetic Market, By Type, 2017 - 2030 (USD Million)
• Table 79 Spain Feed Additives Market, By Type, 2017 - 2030 (USD Million)
• Table 80 Spain Animal Biotechnology Market, By Application, 2017 - 2030 (USD Million)
• Table 81 Spain Animal Biotechnology Market, By Animal Type, 2017 - 2030 (USD Million)
• Table 82 Spain Animal Biotechnology Market, By End-Use, 2017 - 2030 (USD Million)
• Table 83 Asia Pacific Animal Biotechnology Market, By Product Type, 2017 - 2030 (USD Million)
• Table 84 Asia Pacific Diagnostic Test Market, By Type, 2017 - 2030 (USD Million)
• Table 85 Asia Pacific Vaccine Market, By Type, 2017 - 2030 (USD Million)
• Table 86 Asia Pacific Drugs Market, By Type, 2017 - 2030 (USD Million)
• Table 87 Asia Pacific Reproductive And Genetic Market, By Type, 2017 - 2030 (USD Million)
• Table 88 Asia Pacific Feed Additives Market, By Type, 2017 - 2030 (USD Million)
• Table 89 Asia Pacific Animal Biotechnology Market, By Application, 2017 - 2030 (USD Million)
• Table 90 Asia Pacific Animal Biotechnology Market, By Animal Type, 2017 - 2030 (USD Million)
• Table 91 Asia Pacific Animal Biotechnology Market, By End-Use, 2017 - 2030 (USD Million)
• Table 92 China Animal Biotechnology Market, By Product Type, 2017 - 2030 (USD Million)
• Table 93 China Diagnostic Test Market, By Type, 2017 - 2030 (USD Million)
• Table 94 China Vaccine Market, By Type, 2017 - 2030 (USD Million)
• Table 95 China Drugs Market, By Type, 2017 - 2030 (USD Million)
• Table 96 China Reproductive And Genetic Market, By Type, 2017 - 2030 (USD Million)
• Table 97 China Feed Additives Market, By Type, 2017 - 2030 (USD Million)
• Table 98 China Animal Biotechnology Market, By Application, 2017 - 2030 (USD Million)
• Table 99 China Animal Biotechnology Market, By Animal Type, 2017 - 2030 (USD Million)
• Table 100 China Animal Biotechnology Market, By End-Use, 2017 - 2030 (USD Million)
• Table 101 Japan Animal Biotechnology Market, By Product Type, 2017 - 2030 (USD Million)
• Table 102 Japan Diagnostic Test Market, By Type, 2017 - 2030 (USD Million)
• Table 103 Japan Vaccine Market, By Type, 2017 - 2030 (USD Million)
• Table 104 Japan Drugs Market, By Type, 2017 - 2030 (USD Million)
• Table 105 Japan Reproductive And Genetic Market, By Type, 2017 - 2030 (USD Million)
• Table 106 Japan Feed Additives Market, By Type, 2017 - 2030 (USD Million)
• Table 107 Japan Animal Biotechnology Market, By Application, 2017 - 2030 (USD Million)
• Table 108 Japan Animal Biotechnology Market, By Animal Type, 2017 - 2030 (USD Million)
• Table 109 Japan Animal Biotechnology Market, By End-Use, 2017 - 2030 (USD Million)
• Table 110 India Animal Biotechnology Market, By Product Type, 2017 - 2030 (USD Million)
• Table 111 India Diagnostic Test Market, By Type, 2017 - 2030 (USD Million)
• Table 112 India Vaccine Market, By Type, 2017 - 2030 (USD Million)
• Table 113 India Drugs Market, By Type, 2017 - 2030 (USD Million)
• Table 114 India Reproductive And Genetic Market, By Type, 2017 - 2030 (USD Million)
• Table 115 India Feed Additives Market, By Type, 2017 - 2030 (USD Million)
• Table 116 India Animal Biotechnology Market, By Application, 2017 - 2030 (USD Million)
• Table 117 India Animal Biotechnology Market, By Animal Type, 2017 - 2030 (USD Million)
• Table 118 India Animal Biotechnology Market, By End-Use, 2017 - 2030 (USD Million)
• Table 119 South Korea Animal Biotechnology Market, By Product Type, 2017 - 2030 (USD Million)
• Table 120 South Korea Diagnostic Test Market, By Type, 2017 - 2030 (USD Million)
• Table 121 South Korea Vaccine Market, By Type, 2017 - 2030 (USD Million)
• Table 122 South Korea Drugs Market, By Type, 2017 - 2030 (USD Million)
• Table 123 South Korea Reproductive And Genetic Market, By Type, 2017 - 2030 (USD Million)
• Table 124 South Korea Feed Additives Market, By Type, 2017 - 2030 (USD Million)
• Table 125 South Korea Animal Biotechnology Market, By Application, 2017 - 2030 (USD Million)
• Table 126 South Korea Animal Biotechnology Market, By Animal Type, 2017 - 2030 (USD Million)
• Table 127 South Korea Animal Biotechnology Market, By End-Use, 2017 - 2030 (USD Million)
• Table 128 Australia Animal Biotechnology Market, By Product Type, 2017 - 2030 (USD Million)
• Table 129 Australia Diagnostic Test Market, By Type, 2017 - 2030 (USD Million)
• Table 130 Australia Vaccine Market, By Type, 2017 - 2030 (USD Million)
• Table 131 Australia Drugs Market, By Type, 2017 - 2030 (USD Million)
• Table 132 Australia Reproductive And Genetic Market, By Type, 2017 - 2030 (USD Million)
• Table 133 Australia Feed Additives Market, By Type, 2017 - 2030 (USD Million)
• Table 134 Australia Animal Biotechnology Market, By Application, 2017 - 2030 (USD Million)
• Table 135 Australia Animal Biotechnology Market, By Animal Type, 2017 - 2030 (USD Million)
• Table 136 Australia Animal Biotechnology Market, By End-Use, 2017 - 2030 (USD Million)
• Table 137 Latin America Animal Biotechnology Market, By Product Type, 2017 - 2030 (USD Million)
• Table 138 Latin America Diagnostic Test Market, By Type, 2017 - 2030 (USD Million)
• Table 139 Latin America Vaccine Market, By Type, 2017 - 2030 (USD Million)
• Table 140 Latin America Drugs Market, By Type, 2017 - 2030 (USD Million)
• Table 141 Latin America Reproductive And Genetic Market, By Type, 2017 - 2030 (USD Million)
• Table 142 Latin America Feed Additives Market, By Type, 2017 - 2030 (USD Million)
• Table 143 Latin America Animal Biotechnology Market, By Application, 2017 - 2030 (USD Million)
• Table 144 Latin America Animal Biotechnology Market, By Animal Type, 2017 - 2030 (USD Million)
• Table 145 Latin America Animal Biotechnology Market, By End-Use, 2017 - 2030 (USD Million)
• Table 146 Brazil Animal Biotechnology Market, By Product Type, 2017 - 2030 (USD Million)
• Table 147 Brazil Diagnostic Test Market, By Type, 2017 - 2030 (USD Million)
• Table 148 Brazil Vaccine Market, By Type, 2017 - 2030 (USD Million)
• Table 149 Brazil Drugs Market, By Type, 2017 - 2030 (USD Million)
• Table 150 Brazil Reproductive And Genetic Market, By Type, 2017 - 2030 (USD Million)
• Table 151 Brazil Feed Additives Market, By Type, 2017 - 2030 (USD Million)
• Table 152 Brazil Animal Biotechnology Market, By Application, 2017 - 2030 (USD Million)
• Table 153 Brazil Animal Biotechnology Market, By Animal Type, 2017 - 2030 (USD Million)
• Table 154 Brazil Animal Biotechnology Market, By End-Use, 2017 - 2030 (USD Million)
• Table 155 Mexico Animal Biotechnology Market, By Product Type, 2017 - 2030 (USD Million)
• Table 156 Mexico Diagnostic Test Market, By Type, 2017 - 2030 (USD Million)
• Table 157 Mexico Vaccine Market, By Type, 2017 - 2030 (USD Million)
• Table 158 Mexico Drugs Market, By Type, 2017 - 2030 (USD Million)
• Table 159 Mexico Reproductive And Genetic Market, By Type, 2017 - 2030 (USD Million)
• Table 160 Mexico Feed Additives Market, By Type, 2017 - 2030 (USD Million)
• Table 161 Mexico Animal Biotechnology Market, By Application, 2017 - 2030 (USD Million)
• Table 162 Mexico Animal Biotechnology Market, By Animal Type, 2017 - 2030 (USD Million)
• Table 163 Mexico Animal Biotechnology Market, By End-Use, 2017 - 2030 (USD Million)
• Table 164 Argentina Animal Biotechnology Market, By Product Type, 2017 - 2030 (USD Million)
• Table 165 Argentina Diagnostic Test Market, By Type, 2017 - 2030 (USD Million)
• Table 166 Argentina Vaccine Market, By Type, 2017 - 2030 (USD Million)
• Table 167 Argentina Drugs Market, By Type, 2017 - 2030 (USD Million)
• Table 168 Argentina Reproductive And Genetic Market, By Type, 2017 - 2030 (USD Million)
• Table 169 Argentina Feed Additives Market, By Type, 2017 - 2030 (USD Million)
• Table 170 Argentina Animal Biotechnology Market, By Application, 2017 - 2030 (USD Million)
• Table 171 Argentina Animal Biotechnology Market, By Animal Type, 2017 - 2030 (USD Million)
• Table 172 Argentina Animal Biotechnology Market, By End-Use, 2017 - 2030 (USD Million)
• Table 173 Middle East & Africa Animal Biotechnology Market, By Product Type, 2017 - 2030 (USD Million)
• Table 174 Middle East & Africa Diagnostic Test Market, By Type, 2017 - 2030 (USD Million)
• Table 175 Middle East & Africa Vaccine Market, By Type, 2017 - 2030 (USD Million)
• Table 176 Middle East & Africa Drugs Market, By Type, 2017 - 2030 (USD Million)
• Table 177 Middle East & Africa Reproductive And Genetic Market, By Type, 2017 - 2030 (USD Million)
• Table 178 Middle East & Africa Feed Additives Market, By Type, 2017 - 2030 (USD Million)
• Table 179 Middle East & Africa Animal Biotechnology Market, By Application, 2017 - 2030 (USD Million)
• Table 180 Middle East & Africa Animal Biotechnology Market, By Animal Type, 2017 - 2030 (USD Million)
• Table 181 Middle East & Africa Animal Biotechnology Market, By End-Use, 2017 - 2030 (USD Million)
• Table 182 South Africa Animal Biotechnology Market, By Product Type, 2017 - 2030 (USD Million)
• Table 183 South Africa Diagnostic Test Market, By Type, 2017 - 2030 (USD Million)
• Table 184 South Africa Vaccine Market, By Type, 2017 - 2030 (USD Million)
• Table 185 South Africa Drugs Market, By Type, 2017 - 2030 (USD Million)
• Table 186 South Africa Reproductive And Genetic Market, By Type, 2017 - 2030 (USD Million)
• Table 187 South Africa Feed Additives Market, By Type, 2017 - 2030 (USD Million)
• Table 188 South Africa Animal Biotechnology Market, By Application, 2017 - 2030 (USD Million)
• Table 189 South Africa Animal Biotechnology Market, By Animal Type, 2017 - 2030 (USD Million)
• Table 190 South Africa Animal Biotechnology Market, By End-Use, 2017 - 2030 (USD Million)
• Table 191 South Arabia Animal Biotechnology Market, By Product Type, 2017 - 2030 (USD Million)
• Table 192 South Arabia Diagnostic Test Market, By Type, 2017 - 2030 (USD Million)
• Table 193 South Arabia Vaccine Market, By Type, 2017 - 2030 (USD Million)
• Table 194 South Arabia Drugs Market, By Type, 2017 - 2030 (USD Million)
• Table 195 South Arabia Reproductive And Genetic Market, By Type, 2017 - 2030 (USD Million)
• Table 196 South Arabia Feed Additives Market, By Type, 2017 - 2030 (USD Million)
• Table 197 South Arabia Animal Biotechnology Market, By Application, 2017 - 2030 (USD Million)
• Table 198 South Arabia Animal Biotechnology Market, By Animal Type, 2017 - 2030 (USD Million)
• Table 199 South Arabia Animal Biotechnology Market, By End-Use, 2017 - 2030 (USD Million)

List of Figures

• Fig. 1 Market summary (USD Million)
• Fig. 2 Market trends & outlook
• Fig. 3 Market segmentation & scope
• Fig. 4 Market driver relevance analysis (Current & future impact)
• Fig. 5 Market restraint relevance analysis (Current & future impact)
• Fig. 6 Penetration & growth prospect mapping
• Fig. 7 PESTLE
• Fig. 8 Porter's Five Forces Analysis
• Fig. 9 Animal Biotechnology Market, Product type outlook: Key takeaways
• Fig. 10 Animal Biotechnology Market: Product Type movement analysis
• Fig. 11 Global Diagnostic Tests Market, 2017 - 2030 (USD Million)
• Fig. 12 Global Vaccine market, 2017 - 2030 (USD Million)
• Fig. 13 Global Drugs market, 2017 - 2030 (USD Million)
• Fig. 14 Global Reproductive and genetic market, 2017 - 2030 (USD Million)
• Fig. 15 Global Feed additives market, 2017 - 2030 (USD Million)
• Fig. 16 Animal Biotechnology Market, Application outlook: Key takeaways
• Fig. 17 Animal Biotechnology Market, Application Movement analysis
• Fig. 18 Global Diagnosis of Animal Diseases Market, 2017 - 2030 (USD Million)
• Fig. 19 Global Treatment of Animal Diseases market, 2017 - 2030 (USD Million)
• Fig. 20 Global Preventive Care of Animals market, 2017 - 2030 (USD Million)
• Fig. 21 Global Drug Development market, 2017 - 2030 (USD Million)
• Fig. 22 Global Others market, 2017 - 2030 (USD Million)
• Fig. 23 Animal Biotechnology Market, Animal Type outlook: Key takeaways
• Fig. 24 Animal Biotechnology Market Animal Type movement analysis
• Fig. 25 Global Companion Animal Type Market, 2017 - 2030 (USD Million)
• Fig. 26 Global Dogs market, 2017 - 2030 (USD Million)
• Fig. 27 Global Cats market, 2017 - 2030 (USD Million)
• Fig. 28 Global Horses market, 2017 - 2030 (USD Million)
• Fig. 29 Global others market, 2017 - 2030 (USD Million)
• Fig. 30 Global Production Animal market, 2017 - 2030 (USD Million)
• Fig. 31 Global Poultry market, 2017 - 2030 (USD Million)
• Fig. 32 Global Swine market, 2017 - 2030 (USD Million)
• Fig. 33 Global Cattle market, 2017 - 2030 (USD Million)
• Fig. 34 Global Sheep & Goats market, 2017 - 2030 (USD Million)
• Fig. 35 Global Fish market, 2017 - 2030 (USD Million)
• Fig. 36 Animal Biotechnology Market, end-use outlook: Key takeaways
• Fig. 37 Animal Biotechnology Market: End-use movement analysis
• Fig. 38 Global Laboratories market, 2017 - 2030 (USD Million)
• Fig. 39 Global Point-of-care testing/In-house testing market, 2017 - 2030 (USD Million)
• Fig. 40 Global Veterinary Hospitals & Clinics market, 2017 - 2030 (USD Million)
• Fig. 41 Global others market, 2017 - 2030 (USD Million)
• Fig. 42 Regional marketplace: Key takeaways
• Fig. 43 Regional outlook, 2017 & 2030
• Fig. 44 Strategy framework
• Fig. 45 Participant categorization

Animal Biotechnology Market Growth & Trends:

The global animal biotechnology market size is expected to reach USD 49.07 billion by 2030, according to a new report by Grand View Research, Inc. It is expected to expand at a CAGR of 9.2% from 2022 to 2030. The major growth factors are government initiatives and campaigns, innovations and recent advances in animal health biotechnology, growing initiatives to educate regarding animal genetic testing and rising incidence of zoonotic diseases. For instance, in January 2021, the governments of Canada and Ontario are providing up to $4 million through the Canadian Agricultural Partnership to offer farmers improved access to veterinary services when and where they require it.

Due to a rise in the prevalence of COVID-19 across the world, many nations stipulated that only emergency or urgent procedures are certainly necessary for veterinary healthcare. Delays in routine care such as vaccination have led to certain serious health and welfare problems. Moreover, an excess of work after the lifting of COVID-19 restrictions has created further delays in the delivery of such services. Veterinary visits and diagnostic testing were significantly reduced in March, April, and May 2020 but started improving from the third quarter of 2020 with a high growth rate.

Major players observed growth during the pandemic despite the restriction and supply chain disruption. Consolidated revenues of Neogen Corporation were USD 418.2 million in fiscal 2020, an upsurge of 1.0% compared to 2019. Moreover, in June 2022, India's first COVID-19 vaccine Anocovax for animals launched. Besides Anocovac, the Agriculture Minister of India unveiled the 'CAN-CoV-2 ELISA kit' -- specific nucleocapsid protein-based indirect ELISA kit -- for antibody detection against SARS-CoV-2 in canines. Thus, such developments promote overall market growth.

Other attributes contributing to the industry growth comprise improved demand for the usage of animals in agriculture, growing awareness of animal health and welfare, meat, and animal-based products, expanding role of animals in the development of pharmaceuticals for humans, growing pet adoption, and increasing R&D investments from market players. In August 2021, INDICAL BIOSCIENCE GmbH acquired the Check-Points, Dutch R&D-focused corporation.

The industry is highly competitive as major players are focusing on product innovation, new product developments, distribution agreements, and expansion strategies to improve their market penetration. In October 2021, Embark Veterinary, Inc. released its DNA test for purebred dogs. The kit offers purebred owners exclusive, actionable health information to assist in pinpoint diagnostic, treatment plans, and monitoring that can easily be shared with a veterinarian.

Animal Biotechnology Market Report Highlights:

• The vaccine product type segment was the largest revenue-generating segment in 2021. Vaccination is an effective way to lower the disease burden in animals, and it plays an important role in preventive healthcare and disease control. In December 2021, Indian Immunologicals Ltd. introduced Goat Pox Vaccine

• The preventive care of animals application segment accounted for the largest revenue share in 2021 due to the growing adoption of companion animals. An international survey by HABRI and Zoetis indicates a direct relationship between the human-animal bond and consistent veterinary care. Thus, such a human-animal bond advances to better preventive care

• The companion animal type segment is likely to grow lucratively during the forecast period owing to an increase in demand for efficient animal care and the pet-human bond owing to the associated health benefits=

• In the companion animal type segment, dogs held the largest revenue share in 2021. Dogs are prone to many of the same cancers that affect humans. As per the National Cancer Institute, nearly 6 million new cancer diagnoses are made in dogs every year

• In the other, end-use segment, veterinary research institutes, and universities are expected to grow at a lucrative rate over the forecast period owing to growing R&D funding to develop advanced diagnostic tools and therapeutically advanced vaccines and medicines

• North America accounted for the largest revenue share in 2021 owing to high animal awareness levels, the presence of well-established market players, and improved healthcare infrastructure. In October 2021, Zoetis Inc. expanded its manufacturing and development facility in Tullamore, Ireland

Table of Contents

Chapter 1 Research Methodology & Scope

• 1.1 Market Segmentation and Scope
  • 1.1.1 Segment scope
  • 1.1.2 Regional scope
  • 1.1.3 Estimates and forecast timeline
• 1.2 Research Methodology
• 1.3 Information procurement
  • 1.3.1 Purchased database
  • 1.3.2 GVR's internal database
  • 1.3.3 Secondary sources
  • 1.3.4 Primary research
  • 1.3.5 Details of primary research
• 1.4 Information or Data Analysis
  • 1.4.1 Data analysis models
• 1.5 Market Formulation & Validation
• 1.6 Model Details
• 1.7 List of Secondary Sources
• 1.8 Objectives

Chapter 2 Executive Summary

• 2.1 Market Snapshot, 2021 (USD Million)

Chapter 3 Market Variables, Trends & Scope

• 3.1 Market Lineage Outlook
  • 3.1.1 Parent Market Outlook
  • 3.1.2 Ancillary Market Outlook
• 3.2 Penetration & Growth Prospect Mapping
• 3.3 Regulatory Framework
• 3.4 Estimate Animal Population by Key Geographies
• 3.5 Value Chain Analysis
• 3.6 Consumer Preference Analysis
• 3.7 Product Pipeline Analysis
• 3.8 Market Dynamic
  • 3.8.1 Market Driver Analysis
  • 3.8.2 Market Restraint Analysis
  • 3.8.3 Market Opportunity Analysis
  • 3.8.4 Market Challenge Analysis
• 3.9 Industry Analysis
  • 3.9.1 Porter's
  • 3.9.2 PESTLE
• 3.10 COVID-19 Impact Analysis
  • 3.10.1 Current and Future Impact Analysis
  • 3.10.2 Impact of COVID-19 on Market Players

Chapter 4 Competitive Landscape

• 4.1 Market participation categorization
• 4.2 Company Dashboard Analysis
• 4.3 Public Companies
  • 4.3.1 Company Market Position Analysis
  • 4.3.2 Synergy Analysis: Major Deals & Strategic Alliances
• 4.4 List of Market Players

Chapter 5 Animal Biotechnology Market: Product Type Estimates & Trend Analysis

• 5.1 Animal Biotechnology Market: Product Type Movement Analysis
• 5.2 Diagnostic Tests
  • 5.2.1 Diagnostic Tests market estimates and forecasts, 2017 - 2030 (USD Million)
• 5.3 Vaccine
  • 5.3.1 Vaccine market, 2017 - 2030 (USD Million)
• 5.4 Drugs
  • 5.4.1 Drugs market, 2017 - 2030 (USD Million)
• 5.5 Reproductive and Genetic
  • 5.5.1 Reproductive and Genetic market, 2017 - 2030 (USD Million)
• 5.6 Feed Additives
  • 5.6.1 Feed Additives market estimates and forecasts, 2014 - 2025 (USD Million)

Chapter 6 Animal Biotechnology Market: By Application Estimates & Trend Analysis

• 6.1 Animal Biotechnology Market: Application Movement Analysis
• 6.2 Diagnosis of Animal Diseases
  • 6.2.1 Diagnosis of Animal Diseases market estimates and forecasts, 2017 - 2030 (USD Million)
• 6.3 Treatment of Animal Diseases
  • 6.3.1 Treatment of Animal Disease market, 2017 - 2030 (USD Million)
• 6.4 Preventive Care of Animal
  • 6.4.1 Preventive Care of Animal market, 2017 - 2030 (USD Million)
• 6.5 Drug Development
  • 6.5.1 Drug Development market, 2017 - 2030 (USD Million)
• 6.6 Others
  • 6.6.1 Other market estimates and forecasts, 2014 - 2025 (USD Million)

Chapter 7 Animal Biotechnology Market: By Animal Type Estimates & Trend Analysis

• 7.1 Animal Biotechnology Market: Animal Type Movement Analysis
• 7.2 Companion Animal
  • 7.2.1 Companion Animal market, 2017 - 2030 (USD Million)
  • 7.2.2 Dogs
    • 7.2.2.1 Dogs market, 2017 - 2030 (USD Million)
  • 7.2.3 Cats
    • 7.2.3.1 Cats market, 2017 - 2030 (USD Million)
  • 7.2.4 Horses
    • 7.2.4.1 Horses market, 2017 - 2030 (USD Million)
  • 7.2.5 Others
    • 7.2.5.1 Others market, 2017 - 2030 (USD Million)
• 7.3 Production Animal
  • 7.3.1 Production Animal market, 2017 - 2030 (USD Million)
  • 7.3.2 Poultry
    • 7.3.2.1 Poultry market, 2017 - 2030 (USD Million)
  • 7.3.3 Swine
    • 7.3.3.1 Swine market, 2017 - 2030 (USD Million)
  • 7.3.4 Cattle
    • 7.3.4.1 Cattle market, 2017 - 2030 (USD Million)
  • 7.3.5 Sheep & Goats
    • 7.3.5.1 Sheep & Goats market, 2017 - 2030 (USD Million)
  • 7.3.6 Others
    • 7.3.6.1 Others market, 2017 - 2030 (USD Million)

Chapter 8 Animal Biotechnology Market: By End-use Estimates & Trend Analysis

• 8.1 Animal Biotechnology Market: End-use Movement Analysis
• 8.2 Laboratories
  • 8.2.1 Laboratories market estimates and forecasts, 2017 - 2030 (USD Million)
• 8.3 Point-of-care testing/In-house testing
  • 8.3.1 Point-of-care testing/In-house testing market, 2017 - 2030 (USD Million)
• 8.4 Veterinary Hospitals & Clinics
  • 8.4.1 Veterinary Hospitals & Clinics market, 2017 - 2030 (USD Million)
• 8.5 Others
  • 8.5.1 Others market, 2017 - 2030 (USD Million)

Chapter 9 Animal Biotechnology Market: Regional Estimates & Trend Analysis, by Product Type, by Application, by Animal type, and by End-Use

• 9.1 Animal Biotechnology Market Shares by Region, 2017 - 2030 (USD Million)
• 9.2 North America
  • 9.2.1 North America Animal Biotechnology Market estimates and forecasts, 2017 - 2030 (USD Million)
  • 9.2.2 U.S.
    • 9.2.2.1 U.S. market estimates and forecasts, 2017 - 2030 (USD Million)
  • 9.2.3 Canada
    • 9.2.3.1 Canada market estimates and forecasts, (USD Million)
• 9.3 Europe
  • 9.3.1 Europe Animal Biotechnology Market, 2017 - 2030 (USD Million)
  • 9.3.2 Germany
    • 9.3.2.1 Germany Animal Biotechnology Market, (USD Million)
  • 9.3.3 U.K.
    • 9.3.3.1 U.K. Animal Biotechnology Market, 2017 - 2030 (USD Million)
  • 9.3.4 France
    • 9.3.4.1. France Animal Biotechnology Market, 2017 - 2030 (USD Million)
  • 9.3.5 Italy
    • 9.3.5.1 Italy Animal Biotechnology Market, 2017 - 2030 (USD Million)
  • 9.3.6 Spain
    • 9.3.6.1 Spain Animal Biotechnology Market, 2017 - 2030 (USD Million)
• 9.4 Asia Pacific
  • 9.4.1 Asia Pacific Animal Biotechnology Market, 2017 - 2030 (USD Million)
  • 9.4.2 Japan
    • 9.4.2.1 Japan Animal Biotechnology Market, 2017 - 2030 (USD Million)
  • 9.4.3 China
    • 9.4.3.1 China Animal Biotechnology Market, 2017 - 2030 (USD Million)
  • 9.4.4 India
    • 9.4.4.1 India Animal Biotechnology Market, 2017 - 2030 (USD Million)
  • 9.4.5 Australia
    • 9.4.5.1 Australia Animal Biotechnology Market, 2017 - 2030 (USD Million)
• 9.5 Latin America
  • 9.5.1 Latin America Animal Biotechnology Market, 2017 - 2030 (USD Million)
  • 9.5.2 Brazil
    • 9.5.2.1 Brazil Animal Biotechnology Market 2017 - 2030 (USD Million)
  • 9.5.3 Mexico
    • 9.5.3.1 Mexico Animal Biotechnology Market 2017 - 2030 (USD Million)
  • 9.5.4 Argentina
    • 9.5.4.1 Argentina Animal Biotechnology Market 2017 - 2030 (USD Million)
• 9.6 MEA
  • 9.6.1 MEA Animal Biotechnology Market, 2017 - 2030 (USD Million)
  • 9.6.2. Saudi Arabia
    • 9.6.2.1. Saudi Arabia Animal Biotechnology Market, 2017 - 2030 (USD Million)
  • 9.6.3 South Africa
    • 9.6.3.1 South Africa Animal Biotechnology Market, 2017 - 2030 (USD Million)

Chapter 10 Company Profiles

• 10.1 Zoetis
  • 10.1.1 Company overview
  • 10.1.2 Financial performance
  • 10.1.3 Product benchmarking
  • 10.1.4 Strategic initiatives
• 10.2 Boehringer Ingelheim International GmbH
  • 10.2.1 Company overview
  • 10.2.2 Financial performance
  • 10.2.3 Product benchmarking
  • 10.2.4 Strategic initiatives
• 10.3 Biogenesis Bago
  • 10.3.1 Company overview
  • 10.3.2 Financial Performance
  • 10.3.3 Product Benchmarking
  • 10.3.4 Strategic initiatives
• 10.4 Merck & Co.,Inc.
  • 10.4.1 Company Overview
  • 10.4.2 Financial Performance
  • 10.4.3 Product Benchmarking
  • 10.4.4 Strategic initiatives
• 10.5 Virbac
  • 10.5.1 Company Overview
  • 10.5.2 Financial Performance
  • 10.5.3 Product Benchmarking
  • 10.5.4 Strategic initiatives
• 10.6 Elanco
  • 10.6.1 Company Overview
  • 10.6.2 Financial Performance
  • 10.6.3 Product Benchmarking
  • 10.6.4 Strategic initiatives
• 10.7 Idexx Laboratories
  • 10.7.1 Company Overview
  • 10.7.2 Financial Performance
  • 10.7.3 Product Benchmarking
  • 10.7.4 Strategic initiatives
• 10.8 Heska Corporation
  • 10.8.1 Company Overview
  • 10.8.2 Financial Performance
  • 10.8.3 Product Benchmarking
  • 10.8.4 Strategic initiatives
• 10.9 Indian Immunologicals Ltd.
  • 10.9.1 Company Overview
  • 10.9.2 Financial Performance
  • 10.9.3 Product Benchmarking
  • 10.9.4 Strategic initiatives
• 10.10 HESTER BIOSCIENCES LIMITED
  • 10.10.1 Company Overview
  • 10.10.2 Financial Performance
  • 10.10.3 Product Benchmarking
  • 10.10.4 Strategic initiatives